Work Tenaciously, Pursuit Excellence
Genobio Tries to Be a Brave Pathpaver
On December 5th,2015, the marketing management team of Era Biology held an outdoor training.
Every member of this team nee...
Latently infected cells harbor the HIV-1 proviral DNA genome primarily integrated into heterochromatin, allowing the persistence of transcriptionally silent proviruses. Hypoacetylation of histone p...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
Meeting Era Biology at AACC 2023
The AACC congress, the American Association for Clinical Chemistry, is the premier global gathering for laboratory medicine professionals. This year, it will take p...
Era Biology will host global live webinar at 12th July. Due to the fact that WHO has declared that antimicrobial resistance (AMR) is one of the top 10 global public health threats facing humanity. ...
IGL-200 Successfully Approved by Health Canada
May 15th, 2023 – Era Biology’s Fully Automatic Kinetic Tube Reader (IGL-200), along with its adaptation reagents Fungus (1-3)-β-D-Glucan Detection Kit...